Who are Perspective Therapeutics, Inc.'s main suppliers?

Perspective Therapeutics, Inc. (CATX) key suppliers include: U-S-DEPARTMENT-OF-ENERGY, COMECER-SPA, Alpha Tau Medical Ltd., Lantheus Holdings, Inc., Telix Pharmaceuticals Limited. View the full supplier network at chainsifter.com/chain/CATX.

Who are Perspective Therapeutics, Inc.'s major customers?

Perspective Therapeutics, Inc. (CATX) key customers include: Lantheus Holdings, Inc., GT-MEDICAL-TECHNOLOGIES-INC. View the full customer network at chainsifter.com/chain/CATX.

What sector is Perspective Therapeutics, Inc. in?

Perspective Therapeutics, Inc. (CATX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Perspective Therapeutics, Inc. Supplier List (CATX): 5 Verified Suppliers

5Suppliers

2Customers

3Debt Items

17Related Chains

Source-Backed Evidence Depth

Perspective Therapeutics, Inc. (CATX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

11Total relationships

1Distinct source URLs

6High confidence

0.811Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Perspective Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
U-S-DEPARTMENT-OF-ENERGY	U-S-DEPARTMENT-OF-ENERGY	92%	In May 2025 and May 2026, we entered into supply agreements with the U.S. Department of Energy (DOE) under which we will purchase Thorium-228 from the DOE between 2025 and 2027.
COMECER-SPA	COMECER-SPA	90%	In 2024, we entered into a Master Equipment and Services Agreement (MESA) and statements of work (SOWs) thereunder with Comecer SpA (Comecer), pursuant to which we agreed to purchase from Comecer man…
DRTS	Alpha Tau Medical Ltd.	72%	Reciprocal relationship from DRTS graph: e term sheets, effective for a 15-year term following the approval to sell our products, Medison will be responsible for performing regulatory submissions, ma…
LNTH	Lantheus Holdings, Inc.	72%	Reciprocal relationship from LNTH graph: ble for the performance of certain key tasks or functions, for example related to manufacturing or regulatory strategy, or where decisions may be controlled b…
TLX	Telix Pharmaceuticals Limited	72%	Reciprocal relationship from TLX graph: her strengthens our supply chain, reducing environmental impact while maximizing resource utilization. We recognize that the future of isotope supply lies in o…

Perspective Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
LNTH	Lantheus Holdings, Inc.	72%	Reciprocal relationship from LNTH graph: Reciprocal relationship from CATX graph: Reciprocal relationship from LNTH graph: Reciprocal relationship from CATX graph: Reciprocal relationship from LNTH g…
GT-MEDICAL-TECHNOLOGIES-INC	GT-MEDICAL-TECHNOLOGIES-INC	62%	the Company’s clinical-stage alpha therapy developed for the treatment of neuroendocrine tumors. If good-faith negotiations fail, Lantheus has a one-year right to reenter negotiations if a third part…

Perspective Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
CATX-DEBT-8489	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2018-06-30.
CATX-DEBT-8488	Warrants outstanding: 0	90%	xbrl warrant detail from xbrl 2025-12-31.
CATX-DEBT	Debt stack $1.6M	90%	Market cache reports total debt of $1.6M.

Perspective Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Perspective Therapeutics, Inc..

Perspective Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
CATX-OWNER-AVIDITY-PARTNERS-MANAGEMENT-LP	Avidity Partners Management LP	90%	13F overlay lists Avidity Partners Management LP as top holder; 137 tracked holders.

Perspective Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
LNTH	Lantheus Holdings, Inc.	100.00	2	['customer', 'supplier']
RADX	Radiopharm Theranostics Limited	100.00	2
SNSE	Sensei Biotherapeutics, Inc.	100.00	2
TLX	Telix Pharmaceuticals Limited	100.00	1	['supplier']
NBTX	Nanobiotix S.A.	100.00	2
BSX	Boston Scientific Corporation	100.00	2
AZN	AstraZeneca PLC	100.00	2
ATNM	Actinium Pharmaceuticals, Inc.	100.00	2
CLRB	Cellectar Biosciences, Inc.	100.00	2
BMYMP	Bristol-Myers Squibb Co	100.00	2
DRTS	Alpha Tau Medical Ltd.	100.00	1	['supplier']
JANX	Janux Therapeutics, Inc.	100.00	2
MTNB	Matinas BioPharma Holdings, Inc.	50.00	2
BTAI	BioXcel Therapeutics, Inc.	14.78	2
STQN	Strategic Acquisitions, Inc.	14.78	2
REGN	Regeneron Pharmaceuticals, Inc.	14.78	2
MNPR	Monopar Therapeutics Inc.	14.78	2

Perspective Therapeutics, Inc. Supply Chain